Viewing Study NCT00895466


Ignite Creation Date: 2025-12-24 @ 4:25 PM
Ignite Modification Date: 2026-05-18 @ 8:57 PM
Study NCT ID: NCT00895466
Status: UNKNOWN
Last Update Posted: 2009-05-08
First Post: 2009-05-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety Study of the Therapeutic Vaccine PEP223 in Prostate Cancer Patients
Sponsor: Pepscan Therapeutics
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: PEP223-NL-0701
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Chief Medical Officer
Old Organization: Pepscan Therapeutics

Collaborators

Collaborators

Name Class View
None INDUSTRY View